The Canadian (01.07.2014)
Aids Weekly Plus
The Canadian reported on a new program called Link-C to improve hepatitis C virus (HCV) screening and treatment in Canada, particularly in remote areas. In many people, HCV can be controlled if they receive early diagnosis and subsequent treatment. However, this may not be possible in some parts of Canada because of the limited number of healthcare providers with the ability to diagnose HCV infection. University Health Network and the pharmaceutical company Boehringer Ingelheim (Canada) Ltd., joined together to form Link-C to educate and support professionals in HCV diagnosis and treatment. The program expects to increase the number of doctors who can diagnose and treat HCV, especially in remote communities of Ontario.